Cargando…
Second generation androgen receptor antagonist, TQB3720 abrogates prostate cancer growth via AR/GPX4 axis activated ferroptosis
Purpose: Prostate cancer (PCa) poses a great threat to humans. The study aimed to evaluate the potential of TQB3720 in promoting ferroptosis to suppress prostate cancer, providing a theoretical basis for PCa therapy. Methods: PCa cells and nude mice models were divided into TQB3720, enzalutamide (EN...
Autores principales: | Zhang, Zhongqing, Xie, Tianlei, Zhang, Shun, Yin, Haoli, Zhang, Xuyu, Zhang, Siyuan, Chen, Wei, Yu, Ding, Qiu, Xuefeng, Zhao, Wei, Guo, Hongqian, Zhuang, Junlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895946/ https://www.ncbi.nlm.nih.gov/pubmed/36744249 http://dx.doi.org/10.3389/fphar.2023.1110146 |
Ejemplares similares
-
GPX4-independent ferroptosis—a new strategy in disease’s therapy
por: Ma, Tianyu, et al.
Publicado: (2022) -
Contribution of ferroptosis and GPX4’s dual functions to osteoarthritis progression
por: Miao, Yu, et al.
Publicado: (2022) -
Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis
por: Zhou, Jun, et al.
Publicado: (2023) -
CREB stimulates GPX4 transcription to inhibit ferroptosis in lung adenocarcinoma
por: Wang, Zhixian, et al.
Publicado: (2021) -
GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1
por: Wei, Sitian, et al.
Publicado: (2022)